Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk

The reliance on a single transit route for a significant portion of generic drugs underscores the vulnerabilities within the U.S. healthcare supply chain. As geopolitical tensions escalate, the risk of disruptions could lead to increased prices and limited access to essential medications, particularly for low-income populations who depend on generics. This situation highlights the urgent need for diversification in drug manufacturing and supply routes to mitigate risks.